RESUMEN
PURPOSE: To compare the efficacy of 0.1 % w/w Liposomal Amphotericin-B gel with 10 % w/w Povidone-Iodine and saline nasal douching in preventing revision surgery in patients with CAM. STUDY DESIGN: Multi-arm, parallel randomized control trial. STUDY SETTING: The trial was conducted in the Department of ENT, All India Institute of Medical Sciences (AIIMS) Bhubaneswar. METHODS: Participants: Microbiologically and histologically proven cases of mucormycosis who underwent surgical debridement were included in the study. INTERVENTIONS: Postoperatively, patients were randomized into three groups based on the type of topical intervention received, in the form of Lipid-based Amphotericin B gel, povidoneiodine ointment or saline nasal douching. OUTCOME: Requirement of revision surgery in postoperative cases of CAM. RANDOMIZATION: Participants were allotted to one of the three arms by block randomization. BLINDING: Single-blinded trial. RESULTS: Numbers randomized: 15 participants were randomized to each group. Recruitment: Completed recruiting. Numbers analyzed: 15 participants were analyzed in each group. OUTCOMES: Control arm's risk of revision surgery was 4.50 (95 % CI: 1.16-17.44) times than Lipid-based Amphotericin B gel arm and 1.50 (95 % CI: 0.71-3.16) times that of the Povidone- Iodine arm. The difference was statistically significant (p = 0.02) for Amphotericin but not for Povidone-Iodine. CONCLUSIONS: Topical Amphotericin-B gel application in the postoperative cavity can decrease the need for revision surgery and help in early recovery. TRIAL REGISTRATION: CTRI/2021/10/037257. Clinical Trials Registry of India.
Asunto(s)
COVID-19 , Mucormicosis , Humanos , Anfotericina B , SARS-CoV-2 , Povidona Yodada , Mucormicosis/tratamiento farmacológico , Mucormicosis/cirugía , Lípidos , Resultado del TratamientoRESUMEN
Background: Chronic otitis media treatment has evolved, with microscopic surgeries as the gold standard and endoscopic surgeries as a newer addition. Materials and Methods: This retrospective study includes 209 patients who underwent type 1 tympanoplasty, utilizing both endoscopic and microscopic techniques, between January 2019 and December 2022 at a tertiary care institute in India. The study aims to compare hearing outcomes, graft uptake, hospital stay, postoperative pain, and cosmesis between the two groups. Results: Mean AB gap closure was 17.09 + 5.98 dB in the endoscopic group and 16.74 + 5.05 dB in the microscopic group (P = 0.687). The duration of surgery was 79.26 ± 17.37 min in the Endoscopic group and 91.92 ± 15.35 min in the Microscopic group. (P = < 0.00001). The Endoscopic group experienced less post-operative pain, shorter hospital stay (P = < 0.00001, P = 0.0008), and exhibited better cosmetic outcomes (P = 0.00001) compared to the microscopic group. Conclusion: Endoscopic tympanoplasty is a better alternative to microscopic tympanoplasty, delivering comparable hearing outcomes, shorter surgical duration, improved pain scores, and better cosmesis. Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-023-04184-4.
RESUMEN
The predisposing factors of invasive fungal disease in COVID 19 infection are still debatable because of the limited human understanding of the virus with the current literature. In this study, we have tried to correlate the various predisposing factors influencing the clinical profile and treatment outcomes in patients with covid associated mucormycosis (CAM). It is a retrospective analysis of cases of CAM during the second wave of COVID 19 infection, which was managed in the department of Otorhinolaryngology from Dec 1, 2020, to June 10, 2021. The detailed clinical, radiological and management of patients with CAM were collected, recorded, evaluated and correlated with the predisposing factors. Of the total, 46 patients, 44(95.65%) were diabetic and 41 patients had a previous history of steroid intake. When clinical parameters were compared between blood sugar < 200 mg/dl and > 200 mg/dl, the old and newly diagnosed diabetes mellitus in patients with CAM, there was no significant differences in any of the above clinical parameters (p > 0.05), except the hospital stay (p = 0,004). Steroid intake in patients with coexisting DM associated with CAM is considered the most important factor for the development of the CAM. There was are no significant difference in any of the clinical/treatment outcomes in patients with CAM with respect to the initial blood sugar, except for the hospital stay. A large sample size with a long-term follow-up period may be needed for a better understanding of common predisposing factors for the development of CAM.
RESUMEN
BACKGROUND: Medicinal plants are frequently employed by Gujjar and Bakerwal tribes in Rajouri and Poonch districts of Jammu and Kashmir, India for treatment of various ailments in humans and livestock. Hence, extensive field work was conducted to document the ethnomedicinal plants used by these tribes. METHODOLOGY: Ninety one key informants were interviewed using both in situ and ex situ type of survey methods. The data were analyzed using user value (UV), informant consensus factor (Fic), fidelity level (FL) and relative frequency of citation (Rfc). RESULTS: A total of 104 species of medicinal plants used in the treatment of 40 different non-communicable ailments with 138 remedies are reported. Cephalanthera longifolia (L.) Fritsch was recorded for the first time with ethnomedicinal uses and the rest of the species were previously reported with different medicinal uses by other tribal people. Out of 138 remedies, 129 were employed for human ailments and the remaining seven were used to treat livestock. Most of the species were harvested for leaves (24 species). Herbs (66 species) were the major life form used for medicinal purpose and the most common method of remedy preparation was decoction/tea (27.8%). The highest use value plant was Verbascum thapsus L. for the treatment of stomachache and snake bite. CONCLUSIONS: Plants such as Allium humile Kunth, Angelica glauca Edgew, Arnebia benthamii (Wall. ex G. Don) I.M.Johnst, Asparagus racemosus Willd., Balanophora involucrata Hook. f. & Thomson, C. longifolia (L.) Fritsch, Cuscuta epithymum (L.) L., Geranium wallichianum D. Don ex Sweet, Gloriosa superb L., Habenaria intermedia D. Don, Phyllanthus emblica L., Ramaria Formosa (Pers.) Quel. and V. thapsus L. showing high Rfc and FL values may be studied for associated pharmacological activities.